US Diabetes Devices Market

ID: MRFR/HC/13144-HCR
100 Pages
Vikita Thakur
Last Updated: April 06, 2026
US Diabetes Devices Market Research Report: Size, Share, Trend Analysis By Device Type (Blood Glucose Monitors, Insulin Delivery Devices, Continuous Glucose Monitoring Systems, Diabetes Management Software), By End Users (Hospitals, Homecare, Diabetes Clinics, Ambulatory Surgical Centers), By Distribution Channel (Online Pharmacies, Retail Pharmacies, Hospital Pharmacies, Direct Sales) and By Applications (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes) - Growth Outlook & Industry Forecast 2025 To 2035
US Diabetes Devices Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)7.02%
2024 Market Size$ 9.2 Billion
2025 Market Size$ 9.85 Billion
2035 Market Size$ 19.4 Billion
Key Players
Medtronic
Abbott
Roche
Dexcom
Boehringer Ingelheim
Insulet
Trends
  • Technological Advancements
  • Increased Patient Engagement
  • Regulatory Support and Reimbursement
Opportunities
  • Rising Prevalence of Diabetes
  • Growing Awareness and Education
  • Innovations in Device Technology
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Chemicals and Materials, BY Device Type (USD Billion)
      1. 4.1.1 Blood Glucose Monitors
      2. 4.1.2 Insulin Delivery Devices
      3. 4.1.3 Continuous Glucose Monitoring Systems
      4. 4.1.4 Diabetes Management Software
    2. 4.2 Chemicals and Materials, BY End User (USD Billion)
      1. 4.2.1 Hospitals
      2. 4.2.2 Homecare
      3. 4.2.3 Diabetes Clinics
      4. 4.2.4 Ambulatory Surgical Centers
    3. 4.3 Chemicals and Materials, BY Distribution Channel (USD Billion)
      1. 4.3.1 Online Pharmacies
      2. 4.3.2 Retail Pharmacies
      3. 4.3.3 Hospital Pharmacies
      4. 4.3.4 Direct Sales
    4. 4.4 Chemicals and Materials, BY Application (USD Billion)
      1. 4.4.1 Type 1 Diabetes
      2. 4.4.2 Type 2 Diabetes
      3. 4.4.3 Gestational Diabetes
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Chemicals and Materials
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Chemicals and Materials
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Medtronic (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Abbott (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Roche (CH)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Dexcom (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Boehringer Ingelheim (DE)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Insulet (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Novo Nordisk (DK)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Sanofi (FR)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 Johnson & Johnson (US)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 US MARKET ANALYSIS BY DEVICE TYPE
    3. 6.3 US MARKET ANALYSIS BY END USER
    4. 6.4 US MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    5. 6.5 US MARKET ANALYSIS BY APPLICATION
    6. 6.6 KEY BUYING CRITERIA OF CHEMICALS AND MATERIALS
    7. 6.7 RESEARCH PROCESS OF MRFR
    8. 6.8 DRO ANALYSIS OF CHEMICALS AND MATERIALS
    9. 6.9 DRIVERS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
    10. 6.10 RESTRAINTS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
    11. 6.11 SUPPLY / VALUE CHAIN: CHEMICALS AND MATERIALS
    12. 6.12 CHEMICALS AND MATERIALS, BY DEVICE TYPE, 2024 (% SHARE)
    13. 6.13 CHEMICALS AND MATERIALS, BY DEVICE TYPE, 2024 TO 2035 (USD Billion)
    14. 6.14 CHEMICALS AND MATERIALS, BY END USER, 2024 (% SHARE)
    15. 6.15 CHEMICALS AND MATERIALS, BY END USER, 2024 TO 2035 (USD Billion)
    16. 6.16 CHEMICALS AND MATERIALS, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
    17. 6.17 CHEMICALS AND MATERIALS, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Billion)
    18. 6.18 CHEMICALS AND MATERIALS, BY APPLICATION, 2024 (% SHARE)
    19. 6.19 CHEMICALS AND MATERIALS, BY APPLICATION, 2024 TO 2035 (USD Billion)
    20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. 7.2.2 BY END USER, 2025-2035 (USD Billion)
      3. 7.2.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
      4. 7.2.4 BY APPLICATION, 2025-2035 (USD Billion)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

US Diabetes Devices Market Segmentation

US Diabetes Devices Market By Device Type (USD Billion, 2025-2035)

  • Blood Glucose Monitors
  • Insulin Delivery Devices
  • Continuous Glucose Monitoring Systems
  • Diabetes Management Software

US Diabetes Devices Market By End User (USD Billion, 2025-2035)

  • Hospitals
  • Homecare
  • Diabetes Clinics
  • Ambulatory Surgical Centers

US Diabetes Devices Market By Distribution Channel (USD Billion, 2025-2035)

  • Online Pharmacies
  • Retail Pharmacies
  • Hospital Pharmacies
  • Direct Sales

US Diabetes Devices Market By Application (USD Billion, 2025-2035)

  • Type 1 Diabetes
  • Type 2 Diabetes
  • Gestational Diabetes

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.